Caroline Tillett is the Chief Scientific Officer for Kenvue. In this role, Caroline oversees a multi-faceted Research & Development organization including New Product & Packaging Development, Sustainability, Medical Safety and Regulatory Affairs. She leads the company’s efforts to deliver science-based innovation that fuels growth and improves the personal health and wellness of people globally.
Caroline is charged with setting the strategy for the company’s innovation pipeline across its Skin Health, Self Care and Essential Health franchises, and leading a global R&D team dedicated to consumer health research and innovation.
Caroline is a broad - based, global scientific leader with over 20 years of experience in consumer health. She has a passion for creating breakthrough product innovations that benefit people and the planet. A focused scientist driven to deliver innovations that bring together research and consumer understanding, Caroline has advanced many programs through development and commercialization, resulting in consistent category disruption.
Caroline previously served as Global Head, R&D, for Johnson & Johnson Consumer Health, and led the organization through transformations enabling focus on key priorities with new capabilities. Under her leadership, the R&D team put Self Care in the hands of consumers by leaning into digital applications like its first at-home medical device and first-of-its-kind connected, over-the-counter medicine for smokers. In Skin Health, the R&D team focused on more inclusive innovation to better meet the needs of diverse skin states, tones, and types. Across products with a focus on Essential Health, the R&D team leaned into its Healthy Lives Mission by making some of the company’s most iconic products more sustainable. She is an advocate for the underserved and so she leads the Diversity, Equity & Inclusion mission for Kenvue with passion, and she is executive sponsor for Learning & Development which is a key enabler for people to realize their full potential.
Before joining Johnson & Johnson, Caroline served as interim Global Head of Consumer R&D at GSK. She was the R&D leader for the GSK/Novartis joint venture which resulted in the formation of an $8 billion consumer health company. As part of this joint venture, Caroline led the design of the new R&D organization, including reshaping the respiratory pipeline. She also served on the leadership team creating the new GSK/Pfizer Consumer Healthcare joint venture.
Caroline holds a BSc in Applied Chemistry and a PhD in Organic Chemistry from Kingston University, UK.
